RPG Life Sciences Balance Sheet Annual

Trade

BSE: 532983 | NSE: RPGLIFE | ISIN: INE105J01010 | Sector: Biotechnology & Drugs

1,997.65 +11.60 (0.58%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	19.72	24.82	56.94	40.36
Cash Equivalents	16.75	-	-	-
Short Term Investments	91.18	91.33	12.86	0.00
Cashand Short Term Investments	127.65	116.15	69.80	40.36
Accounts Receivable- Trade Net	49.13	37.43	33.59	57.42
Total Receivables Net	49.13	37.45	45.95	72.49
Total Inventory	101.00	95.05	90.62	62.55
Other Current Assets Total	20.31	15.40	0.46	0.39
Total Current Assets	298.09	264.05	206.91	175.85
Property/ Plant/ Equipment Total- Net	181.81	116.30	100.09	87.94
Intangibles Net	28.03	33.40	34.68	37.13
Long Term Investments	1.01	-	0.38	-
Note Receivable- Long Term	1.84	2.35	1.37	2.41
Other Long Term Assets Total	2.09	3.25	1.18	0.06
Total Assets	512.87	419.35	344.61	303.39
Accounts Payable	71.02	64.69	45.50	47.44
Notes Payable/ Short Term Debt	0.00	0.01	0.28	0.52
Other Currentliabilities Total	59.94	38.08	33.97	30.97
Total Current Liabilities	130.96	102.78	80.11	79.69
Long Term Debt	0.00	0.00	0.01	0.55
Total Long Term Debt	0.00	0.00	0.30	0.74
Total Debt	0.00	0.01	0.94	2.02
Deferred Income Tax	0.00	1.97	2.26	-
Other Liabilities Total	7.06	7.00	6.17	6.51
Total Liabilities	138.02	111.75	88.84	86.94
Common Stock Total	13.23	13.23	13.23	13.23
Retained Earnings( Accumulated Deficit)	361.62	294.37	208.08	168.76
Total Equity	374.85	307.60	255.77	216.45
Total Liabilities Shareholders' Equity	512.87	419.35	344.61	303.39
Total Common Shares Outstanding	1.65	1.65	1.65	1.65
Tangible Book Valueper Share Common Eq	209.70	165.79	133.68	108.42
Current Portof LT Debt/ Capital Leases	-	0.00	0.36	0.76
Capital Lease Obligations	-	0.00	0.29	0.19
Prepaid Expenses	-	-	0.08	0.06
Property/ Plant/ Equipment Total- Gross	-	-	117.88	112.79
Accumulated Depreciation Total	-	-	-43.24	-34.29
Additional Paid- In Capital	-	-	34.46	34.46
Accrued Expenses	-	-	-	0.00